Find a Supplier
Add Company
PerkinElmer agrees to acquire SIRION Biotech
Contact Us Subscribe to Newsletter
Subscribe to Supplier

Subscribe to Supplier

.
PerkinElmer agrees to acquire SIRION Biotech

SIRION Biotech GmbH News Releases

Find the latest News from SIRION Biotech GmbH

Page 1 of 3
PerkinElmer agrees to acquire SIRION Biotech
PerkinElmer agrees to acquire SIRION Biotech

Friday 30th July 2021

By  SIRION Biotech… Learn More >
SIRION Biotech scoops double GHP Biotechnology Awards for 2021
SIRION Biotech scoops double GHP Biotechnology Awards for 2021

Friday 28th May 2021

By  SIRION Biotech… Learn More >
SIRION Biotech to collaborate with Sanofi on improved AAV capsids
SIRION Biotech to collaborate with Sanofi on improved AAV capsids

Thursday 11th March 2021

By  SIRION Biotech… Learn More >
Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)
Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)

Friday 12th February 2021

By  SIRION Biotech… Learn More >
SIRION Biotech GmbH licensed its LentiBOOST™ transduction technology to Cellectis
SIRION Biotech GmbH licensed its LentiBOOST™ transduction technology to Cellectis

Wednesday 3rd February 2021

By  SIRION Biotech… Learn More >
SIRION brings viral vector expertise to BioFIT 2020 virtual event
SIRION brings viral vector expertise to BioFIT 2020 virtual event

Wednesday 2nd December 2020

By  SIRION Biotech… Learn More >
SIRION Biotech licenses LentiBOOST™ Technology to Mustang Bio for development of XSCID gene therapy
SIRION Biotech licenses LentiBOOST™ Technology to Mustang Bio for development of XSCID gene therapy

Wednesday 4th November 2020

By  SIRION Biotech… Learn More >
Bavaria supports SIRION in development of AAV-delivered protective antibodies against coronaviruses
Bavaria supports SIRION in development of AAV-delivered protective antibodies against coronaviruses

Thursday 1st October 2020

By  SIRION Biotech… Learn More >
SIRION Biotech defies COVID-19 to achieve 26% growth for first half 2020
SIRION Biotech defies COVID-19 to achieve 26% growth for first half 2020

Friday 4th September 2020

By  SIRION Biotech… Learn More >
SIRION wins Gold Stevie business award after reporting record growth and profits
SIRION wins Gold Stevie business award after reporting record growth and profits

Tuesday 4th August 2020

By  SIRION Biotech… Learn More >
SIRION licenses innovative LentiBOOST™ technology for CAR-T medicines development
SIRION licenses innovative LentiBOOST™ technology for CAR-T medicines development

Wednesday 15th April 2020

By  SIRION Biotech… Learn More >
SIRION Biotech returns to DG-GT gene therapy meeting
SIRION Biotech returns to DG-GT gene therapy meeting

Monday 2nd March 2020

By  SIRION Biotech… Learn More >
Page 1 of 3